Skip to main content
logo
PYC Therapeutics Limited (ASX:PYC)
Australia flag Australia · Delayed Price · Currency is AUD
2.040
-0.090 (-4.23%)
Aug 7, 2026, 4:10 PM AEST

PYC Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
20.5623.4922.0615.8116.043.07
Revenue Growth
-12.49%6.50%39.56%-1.47%421.83%28.33%
Gross Profit
20.5623.4922.0615.8116.043.07
Operating Income
-52.17-53.63-38.86-23.43-14.29-18.76
Net Income
-47.56-50.3-37.73-22.79-13.86-17.77
Earnings Per Share
-0.09-0.10-0.10-0.07-0.04-0.06
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
120.69153.0566.8715.5729.1151.5
Total Debt
0.831.021.110.320.940.73
Net Cash (Debt)
119.86152.0365.7615.2628.1750.77
Net Cash Growth
-21.15%131.18%331.05%-45.84%-44.52%106.14%
Net Cash Per Share
0.210.300.170.050.090.16

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-65.75-51.56-38.59-24.42-21.78-11.79
Capital Expenditures
-0.46-0.98-0.31-0.49-0.39-0.59
Free Cash Flow
-66.22-52.54-38.9-24.91-22.17-12.38
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-253.75%-228.26%-176.15%-148.24%-89.05%-610.16%
Pretax Margin
-234.77%-217.13%-172.76%-147.77%-89.10%-605.98%
Profit Margin
-231.33%-214.11%-171.02%-144.18%-86.41%-577.93%
FCF Margin
-322.07%-223.61%-176.32%-157.61%-138.19%-402.76%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Forward PE
-20.0020.0020.0020.0020.00
PS Ratio
97.5932.1525.3812.1012.89160.37